KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Other Working Capital Changes (2016 - 2025)

Eli Lilly (LLY) has disclosed Other Working Capital Changes for 17 consecutive years, with -$61.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes fell 135.99% year-over-year to -$61.5 million, compared with a TTM value of $620.0 million through Dec 2025, down 81.39%, and an annual FY2025 reading of $620.0 million, down 81.39% over the prior year.
  • Other Working Capital Changes was -$61.5 million for Q4 2025 at Eli Lilly, up from -$4.9 billion in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $5.3 billion in Q2 2025 and bottomed at -$4.9 billion in Q3 2025.
  • Average Other Working Capital Changes over 5 years is $272.9 million, with a median of $178.0 million recorded in 2021.
  • The sharpest move saw Other Working Capital Changes surged 1167.15% in 2024, then plummeted 50565.31% in 2025.
  • Year by year, Other Working Capital Changes stood at $222.7 million in 2021, then plummeted by 33.0% to $149.2 million in 2022, then skyrocketed by 192.36% to $436.2 million in 2023, then tumbled by 60.82% to $170.9 million in 2024, then tumbled by 135.99% to -$61.5 million in 2025.
  • Business Quant data shows Other Working Capital Changes for LLY at -$61.5 million in Q4 2025, -$4.9 billion in Q3 2025, and $5.3 billion in Q2 2025.